EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSEEEG00000013646
Gene Symbol: AURKA
4 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSEEEG00000008649
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSEEEG00000002508
Gene Symbol: BACE1
4 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSEEEG00000009516
Gene Symbol: BDKRB1
1 Cross references
148 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSEEEG00000009522
Gene Symbol: BDKRB2
1 Cross references
286 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSEEEG00000010716
Gene Symbol: BDKRB2
4 Cross references
159 Possible Orthologues:

Bromodomain-Containing Protein 4b

Ensembl ID : ENSEEEG00000012483
Gene Symbol: SI:CH211-79M20.1
3 Cross references
193 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSEEEG00000009960
Gene Symbol: CACNA1C
4 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSEEEG00000017593
Gene Symbol: CACNA1DA
2 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1f Subunit

Ensembl ID : ENSEEEG00000016331
Gene Symbol: CACNA1FB
2 Cross references
177 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, A

Ensembl ID : ENSEEEG00000015790
Gene Symbol: CACNA1SA
4 Cross references
195 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, B

Ensembl ID : ENSEEEG00000013829
Gene Symbol: CACNA1SB
4 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).